These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3385731)

  • 1. Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives.
    Kanojia RM; Press JB; Lever OW; Williams L; McNally JJ; Tobia AJ; Falotico R; Moore JB
    J Med Chem; 1988 Jul; 31(7):1363-8. PubMed ID: 3385731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cardiotonic activity of a series of substituted 4-alkyl-2(1H)-quinazolinones.
    Bandurco VT; Schwender CF; Bell SC; Combs DW; Kanojia RM; Levine SD; Mulvey DM; Appollina MA; Reed MS; Malloy EA
    J Med Chem; 1987 Aug; 30(8):1421-6. PubMed ID: 3039135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents.
    Combs DW; Rampulla MS; Bell SC; Klaubert DH; Tobia AJ; Falotico R; Haertlein B; Lakas-Weiss C; Moore JB
    J Med Chem; 1990 Jan; 33(1):380-6. PubMed ID: 2153210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cardiotonic activity of novel biimidazoles.
    Matthews DP; McCarthy JR; Whitten JP; Kastner PR; Barney CL; Marshall FN; Ertel MA; Burkhard T; Shea PJ; Kariya T
    J Med Chem; 1990 Jan; 33(1):317-27. PubMed ID: 2153209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
    Hagedorn AA; Erhardt PW; Lumma WC; Wohl RA; Cantor E; Chou YL; Ingebretsen WR; Lampe JW; Pang D; Pease CA
    J Med Chem; 1987 Aug; 30(8):1342-7. PubMed ID: 3039132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents: 4-ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties.
    Kanojia RM; Lever OW; Press JB; Williams L; Werblood HM; Giardino EC; Falotico R; Tobia AJ
    J Med Chem; 1989 May; 32(5):990-7. PubMed ID: 2709385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of 6-substituted purine derivatives as novel selective positive inotropes.
    Press JB; Falotico R; Hajos ZG; Sawyers RA; Kanojia RM; Williams L; Haertlein B; Kauffman JA; Lakas-Weiss C; Salata JJ
    J Med Chem; 1992 Nov; 35(24):4509-15. PubMed ID: 1335073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
    Davey D; Erhardt PW; Lumma WC; Wiggins J; Sullivan M; Pang D; Cantor E
    J Med Chem; 1987 Aug; 30(8):1337-42. PubMed ID: 3039131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotonic agents. 1-Methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3 (2H)-isoquinolinones and related compounds. Synthesis and activity.
    Kaiho T; San-Nohe K; Kajiya S; Suzuki T; Otsuka K; Ito T; Kamiya J; Maruyama M
    J Med Chem; 1989 Feb; 32(2):351-7. PubMed ID: 2913296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
    Hagen V; Hagen A; Krause EG; Klauschenz E
    Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
    J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
    Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
    J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents.
    Bagli J; Bogri T; Palameta B; Rakhit S; Peseckis S; McQuillan J; Lee DK
    J Med Chem; 1988 Apr; 31(4):814-23. PubMed ID: 2832602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors.
    Fossa P; Boggia R; Lo Presti E; Mosti L; Dorigo P; Floreani M
    Farmaco; 1997; 52(8-9):523-30. PubMed ID: 9507660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
    de Cheffoy de Courcelles D; de Loore K; Freyne E; Janssen PA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
    Sircar I; Weishaar RE; Kobylarz D; Moos WH; Bristol JA
    J Med Chem; 1987 Nov; 30(11):1955-62. PubMed ID: 2822926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents.
    Mertens A; Müller-Beckmann B; Kampe W; Hölck JP; von der Saal W
    J Med Chem; 1987 Aug; 30(8):1279-87. PubMed ID: 3612681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Heteroaryl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin -2(1H)-one derivatives with cardiac stimulant activity.
    Bell AS; Campbell SF; Roberts DA; Ruddock KS
    J Med Chem; 1989 Sep; 32(9):2042-9. PubMed ID: 2769678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.